Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 111

Results For "International"

1333 News Found

WeylChem inaugurates new multi-purpose custom manufacturing plant in France
News | April 13, 2022

WeylChem inaugurates new multi-purpose custom manufacturing plant in France

The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules


Venus Remedies gets CII's Responsible Export Organisation Certification
News | April 13, 2022

Venus Remedies gets CII's Responsible Export Organisation Certification

A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess


Pharmapack Europe 2022 to open on May 18-19 in Paris
Packaging | April 12, 2022

Pharmapack Europe 2022 to open on May 18-19 in Paris

Pharmapack trends are a key barometer of global device and packing opportunities in 2022


CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
Biotech | April 11, 2022

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid

These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection


Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
Startup | April 11, 2022

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas


Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
Biotech | April 08, 2022

Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer

The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC


Lupin launches Merzee capsules in the United States
Drug Approval | April 07, 2022

Lupin launches Merzee capsules in the United States

Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International


BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022
News | April 07, 2022

BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022

Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"


Revenue growth to moderate, non-Covid-19 revenue to drive profitability
News | April 06, 2022

Revenue growth to moderate, non-Covid-19 revenue to drive profitability

Ind-Ra maintains a neutral outlook for healthcare in FY23


Abott gets USFDA approval for leadless pacemaker
Drug Approval | April 05, 2022

Abott gets USFDA approval for leadless pacemaker

Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced